InflaRx IFRX
NASDAQ IFRX
$1.21 -0.10 (-7.63%)
At close: Nov 10, 2026 · 4:00 PM EST

InflaRx (IFRX) Other financing activities (as filed) (2016 - 2025)

Updated

InflaRx's Other financing activities (as filed) was $14.59 million in FY2025, compared with -$350,384 in FY2024.

Analysis

InflaRx (IFRX) Other financing activities (as filed) (2016 - 2025) Analysis & Trends

From FY2016 onward, InflaRx has reported Other financing activities (as filed) for 9 years.

  • The FY2025 figure marks the highest annual Other financing activities (as filed) in data going back to FY2016.
  • Per Business Quant data, Other financing activities (as filed) in earlier years was -$350,384 in FY2024, -$3.64 million in FY2023, -$50.31 million in FY2022 and -$4.99 trillion in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 InflaRx 85.79 Mn -160.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.28 Mn
Jun 30, 2025 -2.21 Mn
Mar 31, 2025 13.59 Mn
Dec 31, 2021 -4,826.66 Bn
Mar 31, 2021 -5.09 Mn
Sep 30, 2018 -308.23
Jun 30, 2018 -4.54 Mn
Dec 31, 2017 -65,936.22
Dec 31, 2016 -41,029.52
API Access

InflaRx Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IFRX&period=max&api_key=YOUR_API_KEY